421 related articles for article (PubMed ID: 35978514)
1. Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease.
Wang Z; Weaver DF
Int Immunopharmacol; 2022 Sep; 110():109070. PubMed ID: 35978514
[TBL] [Abstract][Full Text] [Related]
2. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
3. Zinc utilization by microglia in Alzheimer's disease.
Shippy DC; Oliai SF; Ulland TK
J Biol Chem; 2024 May; 300(5):107306. PubMed ID: 38648940
[TBL] [Abstract][Full Text] [Related]
4. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
Cai Y; Liu J; Wang B; Sun M; Yang H
Front Immunol; 2022; 13():856376. PubMed ID: 35558075
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer's disease.
Wang Z; Wang Y; Pasangulapati JP; Stover KR; Liu X; Schier SW; Weaver DF
Eur J Med Chem; 2021 Oct; 222():113565. PubMed ID: 34118718
[TBL] [Abstract][Full Text] [Related]
6. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
7. Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis.
Doens D; Fernández PL
J Neuroinflammation; 2014 Mar; 11():48. PubMed ID: 24625061
[TBL] [Abstract][Full Text] [Related]
8. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
[TBL] [Abstract][Full Text] [Related]
9. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
10. Microglial Activation and Priming in Alzheimer's Disease: State of the Art and Future Perspectives.
Bivona G; Iemmolo M; Agnello L; Lo Sasso B; Gambino CM; Giglio RV; Scazzone C; Ghersi G; Ciaccio M
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614325
[TBL] [Abstract][Full Text] [Related]
11. TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis.
Zhang H; Wang H; Gao F; Yang J; Xu Y; Fu Y; Cai M; Zhang X; Yang Q; Tong K; Hu Y; Chen H; Ma C; He W; Zhang J
Neurobiol Aging; 2021 Oct; 106():292-303. PubMed ID: 34340010
[TBL] [Abstract][Full Text] [Related]
12. Receptor-ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology.
Lau SF; Fu AKY; Ip NY
J Neurochem; 2023 Sep; 166(6):891-903. PubMed ID: 37603311
[TBL] [Abstract][Full Text] [Related]
13. New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer's Disease.
Li N; Deng M; Hu G; Li N; Yuan H; Zhou Y
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421736
[TBL] [Abstract][Full Text] [Related]
14. Microglial priming in Alzheimer's disease.
Li JW; Zong Y; Cao XP; Tan L; Tan L
Ann Transl Med; 2018 May; 6(10):176. PubMed ID: 29951498
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation.
Anwar S; Rivest S
Expert Opin Ther Targets; 2020 Apr; 24(4):331-344. PubMed ID: 32129117
[No Abstract] [Full Text] [Related]
16. New insights in drug development for Alzheimer's disease based on microglia function.
Qiao O; Ji H; Zhang Y; Zhang X; Zhang X; Liu N; Huang L; Liu C; Gao W
Biomed Pharmacother; 2021 Aug; 140():111703. PubMed ID: 34083109
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
18. Potential Alzheimer's disease drug targets identified through microglial biology research.
Lepiarz-Raba I; Hidayat T; Hannan AJ; Jawaid A
Expert Opin Drug Discov; 2024 May; 19(5):587-602. PubMed ID: 38590098
[TBL] [Abstract][Full Text] [Related]
19. Microglial roles in Alzheimer's disease: An agent-based model to elucidate microglial spatiotemporal response to beta-amyloid.
Weathered C; Bardehle S; Yoon C; Kumar N; Leyns CEG; Kennedy ME; Bloomingdale P; Pienaar E
CPT Pharmacometrics Syst Pharmacol; 2024 Mar; 13(3):449-463. PubMed ID: 38078626
[TBL] [Abstract][Full Text] [Related]
20. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
Webers A; Heneka MT; Gleeson PA
Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
